In the Portuguese population where the SELENOS promoter SNP was originally found to increase the risk of HT [32], we recently found that this risk was further modulated by the genotype of the three functional SNPs (rs35652124, rs6706649, and rs6721961) in the promoter of NFE2L2 [34]. The gene discussed is NFE2L2; the disease is hematocrit.